NEW YORK, Feb. 4 (GenomeWeb News) - PrecisionMed and Phenomenome Discoveries will collaborate to develop diagnostics for Alzheimer's disease and bipolar disorder, the companies said today.
Phenomenome, based in Saskatoon, Canada, will contribute its metabolomics technology to find metabolites that differ between patients and controls.
PrecisionMed, a human biobank located in San Diego, will provide clinical samples and information.